InvestorsHub Logo
Followers 103
Posts 4960
Boards Moderated 0
Alias Born 10/20/2015

Re: XenaLives post# 182440

Thursday, 02/21/2019 7:23:49 AM

Thursday, February 21, 2019 7:23:49 AM

Post# of 470044
Forbes Magazine also had a glowing article on wonder boy VJ CEO of AXON speaking of its brilliant new approach to ALZ and it's very promising clinical trials shortly after AXON's IPO. Biohavens IPO was two months ago. This company will appear on conviction buy lists of Wall Street firms just as AXON was. It will get a lot of press coverage in the Financial news and magazines. It will get a lot of press and pump but soon the Wall Street RICO machine will start to sell its shares it got for pennies pre IPO to a gullible public no matter how the trials are progressing the Stock will almost certainly crater at some point. IPOs of non revenue biotech nearly universally crater at some point about a six months to a year out after the lock up period for the initial stock purchases in the IPO. Funny how some would promote Biohaven while constantly denigrating AVXL.
Contrast non revenue IPOs with the ones where the company was already making a profit or had a firm grim of domination in their business sectors like Google or Amazon.
I wish Biohaven luck, they will need it. However any investor who buys stock in the company during this IPO lock up period would assuredly get taken to the cleaners by the Wall Street RICO IPO machine.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News